148 related articles for article (PubMed ID: 29423110)
1. Potential for subsets of wt-NPM1 primary AML blasts to respond to retinoic acid treatment.
Bunaciu RP; MacDonald RJ; Gao F; Johnson LM; Varner JD; Wang X; Nataraj S; Guzman ML; Yen A
Oncotarget; 2018 Jan; 9(3):4134-4149. PubMed ID: 29423110
[TBL] [Abstract][Full Text] [Related]
2. Evidence of off-target effects of bosutinib that promote retinoic acid-induced differentiation of non-APL AML cells.
Kazim N; Yen A
Cell Cycle; 2021 Dec; 20(24):2638-2651. PubMed ID: 34836491
[TBL] [Abstract][Full Text] [Related]
3. The AhR agonist VAF347 augments retinoic acid-induced differentiation in leukemia cells.
Ibabao CN; Bunaciu RP; Schaefer DM; Yen A
FEBS Open Bio; 2015; 5():308-18. PubMed ID: 25941627
[TBL] [Abstract][Full Text] [Related]
4. Reprogramming acute myeloid leukemia into sensitivity for retinoic-acid-driven differentiation.
van Gils N; Verhagen HJMP; Smit L
Exp Hematol; 2017 Aug; 52():12-23. PubMed ID: 28456748
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid induction of CD38 antigen expression on normal and leukemic human myeloid cells: relationship with cell differentiation.
Prus E; Fibach E
Leuk Lymphoma; 2003 Apr; 44(4):691-8. PubMed ID: 12769347
[TBL] [Abstract][Full Text] [Related]
6. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
[TBL] [Abstract][Full Text] [Related]
7. RRD-251 enhances all-trans retinoic acid (RA)-induced differentiation of HL-60 myeloblastic leukemia cells.
Wallace AS; Supnick HT; Bunaciu RP; Yen A
Oncotarget; 2016 Jul; 7(29):46401-46418. PubMed ID: 27331409
[TBL] [Abstract][Full Text] [Related]
8. The efficient generation of immunocompetent dendritic cells from leukemic blasts in acute myeloid leukemia: a local experience.
Bagheri K; Alimoghadam K; Pourfathollah AA; Hassan ZM; Hajati J; Moazzeni SM
Pathol Oncol Res; 2009 Jun; 15(2):257-67. PubMed ID: 18807213
[TBL] [Abstract][Full Text] [Related]
9. Expression of retinoic acid receptor-alpha mRNA in human leukemia cells with variable responsiveness to retinoic acid.
Gallagher RE; Said F; Pua I; Papenhausen PR; Paietta E; Wiernik PH
Leukemia; 1989 Nov; 3(11):789-95. PubMed ID: 2554072
[TBL] [Abstract][Full Text] [Related]
10. Role for Fgr and Numb in retinoic acid-induced differentiation and G0 arrest of non-APL AML cells.
Kazim N; Yen A
Oncotarget; 2021 Jun; 12(12):1147-1164. PubMed ID: 34136084
[TBL] [Abstract][Full Text] [Related]
11. Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia.
Nabbouh AI; Hleihel RS; Saliba JL; Karam MM; Hamie MH; Wu HJM; Berthier CP; Tawil NM; Bonnet PA; Deleuze-Masquefa C; El Hajj HA
Cancer; 2017 May; 123(9):1662-1673. PubMed ID: 28055106
[TBL] [Abstract][Full Text] [Related]
12. [Potentiation of arsenic trioxide-induced apoptosis by retinoic acid in retinoic acid sensitive and resistant HL-60 myeloid leukemia cells].
Huang X
Chin Med J (Engl); 2000 Jun; 113(6):498-501. PubMed ID: 11775865
[TBL] [Abstract][Full Text] [Related]
13. The effect of anti-CD44 monoclonal antibodies on differentiation and proliferation of human acute myeloid leukemia cells.
Gadhoum Z; Delaunay J; Maquarre E; Durand L; Lancereaux V; Qi J; Robert-Lezenes J; Chomienne C; Smadja-Joffe F
Leuk Lymphoma; 2004 Aug; 45(8):1501-10. PubMed ID: 15370200
[TBL] [Abstract][Full Text] [Related]
14. Smac mimetic induces cell death in a large proportion of primary acute myeloid leukemia samples, which correlates with defined molecular markers.
Lueck SC; Russ AC; Botzenhardt U; Schlenk RF; Zobel K; Deshayes K; Vucic D; Döhner H; Döhner K; Fulda S; Bullinger L
Oncotarget; 2016 Aug; 7(31):49539-49551. PubMed ID: 27385100
[TBL] [Abstract][Full Text] [Related]
15. c-Cbl interacts with CD38 and promotes retinoic acid-induced differentiation and G0 arrest of human myeloblastic leukemia cells.
Shen M; Yen A
Cancer Res; 2008 Nov; 68(21):8761-9. PubMed ID: 18974118
[TBL] [Abstract][Full Text] [Related]
16. New strategies for the treatment of acute myelogenous leukemia: differentiation induction--present use and future possibilities.
Bruserud O; Gjertsen BT
Stem Cells; 2000; 18(3):157-65. PubMed ID: 10840068
[TBL] [Abstract][Full Text] [Related]
17. INPP4B promotes cell survival via SGK3 activation in NPM1-mutated leukemia.
Jin H; Yang L; Wang L; Yang Z; Zhan Q; Tao Y; Zou Q; Tang Y; Xian J; Zhang S; Jing Y; Zhang L
J Exp Clin Cancer Res; 2018 Jan; 37(1):8. PubMed ID: 29343273
[TBL] [Abstract][Full Text] [Related]
18. CBL exon 8/9 mutants activate the FLT3 pathway and cluster in core binding factor/11q deletion acute myeloid leukemia/myelodysplastic syndrome subtypes.
Reindl C; Quentmeier H; Petropoulos K; Greif PA; Benthaus T; Argiropoulos B; Mellert G; Vempati S; Duyster J; Buske C; Bohlander SK; Humphries KR; Hiddemann W; Spiekermann K
Clin Cancer Res; 2009 Apr; 15(7):2238-47. PubMed ID: 19276253
[TBL] [Abstract][Full Text] [Related]
19. Induction of differentiation and apoptosis- a possible strategy in the treatment of adult acute myelogenous leukemia.
Bruserud O; Gjertsen BT; Huang Ts
Oncologist; 2000; 5(6):454-62. PubMed ID: 11110596
[TBL] [Abstract][Full Text] [Related]
20. The differentiating effect of retinoic acid and vincristine on acute myeloid leukemia.
Leung MF; Wong KF
J Hematother; 1999 Jun; 8(3):275-9. PubMed ID: 10417051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
